EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,416 | -53.1% | 14,478 | +8.3% | 0.00% | – |
| Q2 2023 | $9,410 | -41.8% | 13,367 | -2.4% | 0.00% | -100.0% |
| Q4 2022 | $16,161 | -86.5% | 13,696 | +0.7% | 0.00% | -83.3% |
| Q1 2021 | $120,000 | -63.4% | 13,600 | -49.0% | 0.01% | -57.1% |
| Q4 2020 | $328,000 | +182.8% | 26,650 | +120.2% | 0.01% | +133.3% |
| Q2 2020 | $116,000 | -32.9% | 12,100 | -52.5% | 0.01% | -50.0% |
| Q1 2020 | $173,000 | – | 25,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |